CVE-2017-18228 — MEDIUM (5.4)

Q: What is CVE-2017-18228?

CVE-2017-18228 is a vulnerability with a CVSS score of 5.4 (MEDIUM). Remedy Mid Tier in BMC Remedy AR System 9.1 allows XSS via the ATTKey parameter in an arsys/servlet/AttachServlet request.

Q: How severe is CVE-2017-18228?

CVE-2017-18228 has been rated MEDIUM with a CVSS base score of 5.4/10. Review the CVSS metrics above for detailed severity breakdown.

Q: Is there a patch for CVE-2017-18228?

Check the references section above for vendor advisories and patch information. Affected products include: Bmc Remedy Action Request System.

Vulnerability Description

Remedy Mid Tier in BMC Remedy AR System 9.1 allows XSS via the ATTKey parameter in an arsys/servlet/AttachServlet request.

CVSS Score

5.4

MEDIUM

CVSS:3.0/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N

Attack Vector

NETWORK

Attack Complexity

LOW

Privileges Required

LOW

User Interaction

REQUIRED

Scope

CHANGED

Confidentiality

LOW

Integrity

LOW

Availability

NONE

Affected Products

Vendor	Product	Versions
Bmc	Remedy Action Request System	<= 9.1

Related Weaknesses (CWE)

CWE-79

References

https://communities.bmc.com/thread/164169Vendor Advisory
https://communities.bmc.com/thread/164169Vendor Advisory

FAQ

What is CVE-2017-18228?

CVE-2017-18228 is a vulnerability with a CVSS score of 5.4 (MEDIUM). Remedy Mid Tier in BMC Remedy AR System 9.1 allows XSS via the ATTKey parameter in an arsys/servlet/AttachServlet request.

How severe is CVE-2017-18228?

CVE-2017-18228 has been rated MEDIUM with a CVSS base score of 5.4/10. Review the CVSS metrics above for detailed severity breakdown.

Is there a patch for CVE-2017-18228?

Check the references section above for vendor advisories and patch information. Affected products include: Bmc Remedy Action Request System.